France begins trials of new COVID vaccine
Other countries
- 25 February, 2021
- 06:11
Add Report.az to preferred Google sources
Stay up to date with the top news!
French biotechnology company Xenothera has begun clinical trials of its coronavirus vaccine, Report informs with reference to TASS.
The vaccine is named Xav-19.
The vaccine testing program follows Polycor standards, one of 15 types of clinical trials of drugs approved by the French medical authorities. The trial will be carried out in 40 hospitals in the country, coordinated by the University Hospital of Nantes.
The drug will be tested on 400 volunteer patients. Currently, 67 patients from 21 hospitals are participating in the trial.
The tests are supposed to determine the level of vaccine effectiveness with great accuracy.
Latest News
15:58
Azerbaijan, China discuss expanding air connectivity
Tourism
15:51
TikTok's algorithms deemed dangerous to mental health of EU users
Other countries
15:34
Unsettled weather to persist in Azerbaijan until November 10, weather service warns
Ecology
15:21
Azerbaijan mulls expanding trade ties with Suriname
Business
15:10
MiniBoss Business School opens enrollment at its second Baku branch
Business
15:08
Lithuanian foreign minister meets Azerbaijani presidential adviser in Vilnius
Foreign policy
15:00
Fox News: US considers November 9 favorable day to resume strikes on Iran
Other countries
14:52
Gold makes up 16.6% of Georgia's international reserves
Region
14:49
President Ilham Aliyev and First Lady Mehriban Aliyeva attend opening of Zangilan City Education Complex
Domestic policy